Targeting TRIM5 alpha in HIV cure strategies for the CRISPR-Cas9 era
In the past decade, studies of innate immune activity against HIV-1 and other retroviruses have revealed a powerful array of host factors that can attack the virus at various stages of its life cycle in human and primate cells, raising the prospect that these antiviral factors could be manipulated i...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Published: |
Frontiers Media
2017
|